Suggestions
Mike Hoerres
Commercialization and Growth Advisor - Life Sciences
Mike Hoerres is a relentless enterprise leader with a values-driven mindset who excels in building and growing organizations, delivering long-term value for shareholders, employees, partners, and customers.
With a proven track record as an entrepreneurial CEO, clinical market development expert, fundraiser, marketer, sales leader, and strategic investor, Mike has successfully developed and commercialized new products and markets in life science technology platforms including spatial biology, AI/Machine learning, DNA microarrays, PCR, and molecular cloning.
Notably, at Cernostics, Mike led a team that developed and commercialized TissueCypher, an Advanced Diagnostics Laboratory Test predicting the development of esophageal adenocarcinoma, a fatal cancer.
Mike's expertise spans biomarker discovery, validation, translational medicine, and diagnostics across various therapeutic areas such as oncology, gastroenterology, autoimmune diseases, and transplant rejection.
His experience includes overseeing complex clinical development programs, coordinating translational medicine projects, and leveraging clinical data alongside genomic and proteomic tools to advance diagnostic, prognostic, and predictive tests.
An advocate for understanding how genomic and proteomic tests can improve patient outcomes, Mike excels at translating this knowledge into creating value for patients, providers, and payers through collaborative efforts.
He holds a Master's degree in Molecular Biology from San Diego State University and a Bachelor's degree in Biochemistry from the University of Wisconsin-Milwaukee.
Mike has held key roles in various organizations such as Board of Directors at AEGEA BIOTECHNOLOGIES, Founder at Aquinas Life Science Advisors, LLC, Interim President at Cernostics within Castle Biosciences, Inc., CEO at Cernostics, Inc., Principal at Geisinger Health System, VP of Business Development at Source MDx, Clinical Market Development Manager at Affymetrix, Director of Business Development at Incyte Genomics, and Regional Sales Manager at Stratagene.